MyFinsight
Home
Blog
About
2031 and thereafter
$31,936K
2030
$6,449K
2028
$6,449K
2027
$6,449K
2027-Cost Of Sales Product
$6,382K
2026 (remainder of
year)
$3,224K
2027-Selling General And
Administrative
$67K
Cash and cash
equivalents
$5,098,041K
(84.98%↑ Y/Y)
Accounts receivable, net
$1,056,177K
(37.03%↑ Y/Y)
Inventories, net
$732,603K
(45.69%↑ Y/Y)
Prepaid expenses and
other current assets
$328,984K
(17.28%↑ Y/Y)
Property, plant and
equipment, net
$1,643,286K
(1.70%↑ Y/Y)
Operating lease
right-of-use assets
$145,987K
(0.15%↑ Y/Y)
Other non-current
assets
$109,581K
(-32.24%↓ Y/Y)
Intangible assets, net
$60,956K
(-6.06%↓ Y/Y)
Total current assets
$7,215,805K
(67.41%↑ Y/Y)
Total non-current
assets
$1,959,810K
(-1.43%↓ Y/Y)
Total assets
$9,175,615K
(45.68%↑ Y/Y)
Total liabilities and
shareholders equity
$9,175,615K
(45.68%↑ Y/Y)
Total shareholders
equity
$5,173,998K
(37.22%↑ Y/Y)
Total liabilities
$4,001,617K
(58.30%↑ Y/Y)
Accumulated deficit
-$7,855,539K
(7.70%↑ Y/Y)
Accumulated other
comprehensive loss
-$25,370K
(77.69%↑ Y/Y)
Additional paid-in capital
$13,054,760K
(5.32%↑ Y/Y)
Total current
liabilities
$2,119,187K
(-4.10%↓ Y/Y)
Total non-current
liabilities
$1,882,430K
(491.81%↑ Y/Y)
Ordinary shares, 0.0001
par value per share...
$147K
(2.80%↑ Y/Y)
Accrued expenses and
other payables
$1,264,264K
(39.10%↑ Y/Y)
Accounts payable
$470,299K
(30.36%↑ Y/Y)
Short-term debt
$190,896K
(-76.39%↓ Y/Y)
Sale of future
royalty liability,...
$89,278K
Tax payable
$76,315K
(1278.52%↑ Y/Y)
Operating lease
liabilities, current portion
$21,953K
(27.26%↑ Y/Y)
Research and development
cost share...
$6,182K
(-94.33%↓ Y/Y)
Long-term debt
$882,163K
(503.84%↑ Y/Y)
Sale of future
royalty liability,...
$817,035K
Other long-term
liabilities
$77,644K
(23.09%↑ Y/Y)
Deferred tax liabilities
$57,388K
(30.15%↑ Y/Y)
Operating lease
liabilities, non-current...
$48,200K
(-10.64%↓ Y/Y)
Back
Back
Balance Sheet
BeOne Medicines Ltd. (BEIGF)
BeOne Medicines Ltd. (BEIGF)
source: myfinsight.com